Glioblastoma Research & Use Of Immunotherapy
Considered to be a method used to target the most common type of brain tumor known, glioblastoma research has had a great amount of support given. I think that this is great to know because the potential that this has is great. You can tell by just how work is done in order to help the problem at hand. Knowing that there are many different reports that are posted about the matter, you should know that I have kept my focus on those which boast great potential.
An article that was posted on Seeking Alpha talked about a 60-patient phase I/II trial about to be done. Northwest Biotherapeutics would be in charge as the process would be conducted at the MD Anderson Cancer Center. With the immunotherapy DCVax-Direct put into effect, it would grant patients a standard dose. This would then work into the Phase II portion of the experiment, which would then be able to determine a tumor shrinkage endpoint thanks to a RECIST measurement, which goes to show how complex the system is.
There are many features to consider but I think one of the most notable, to me, was the usage of human cells. A patient's own cells would be used in the experiment and it was something that drew me to stem cell research as well. I think that this has gained a number of supporters in the past and it shows just how driven people are to certain causes. When talking about this subject matter, I think that it is easy to make such a connection.
Glioblastoma research is an important idea to consider, especially when you think about the common nature of these particular tumors. It seems like these are the ones most seen in an entire group; at least 120 types are known. I don't think that companies the likes of Voices against Brain Cancer will be able to deny this kind of idea, either. Hopefully there is more done in order to help those impacted and that these kinds of stories are reported on in the future.
It's clear that Northwest has done a great deal of good when it comes to this particular method. It seems like even more will be done in the future, as the article talked a phase III trial that would help the patients along. From what I've seen, solid results will come down the pipeline in 2014, which would be great for those working in this field of research. I believe that, with so many details in existence, it seems like even more of them will be able to help those afflicted in the long run.
An article that was posted on Seeking Alpha talked about a 60-patient phase I/II trial about to be done. Northwest Biotherapeutics would be in charge as the process would be conducted at the MD Anderson Cancer Center. With the immunotherapy DCVax-Direct put into effect, it would grant patients a standard dose. This would then work into the Phase II portion of the experiment, which would then be able to determine a tumor shrinkage endpoint thanks to a RECIST measurement, which goes to show how complex the system is.
There are many features to consider but I think one of the most notable, to me, was the usage of human cells. A patient's own cells would be used in the experiment and it was something that drew me to stem cell research as well. I think that this has gained a number of supporters in the past and it shows just how driven people are to certain causes. When talking about this subject matter, I think that it is easy to make such a connection.
Glioblastoma research is an important idea to consider, especially when you think about the common nature of these particular tumors. It seems like these are the ones most seen in an entire group; at least 120 types are known. I don't think that companies the likes of Voices against Brain Cancer will be able to deny this kind of idea, either. Hopefully there is more done in order to help those impacted and that these kinds of stories are reported on in the future.
It's clear that Northwest has done a great deal of good when it comes to this particular method. It seems like even more will be done in the future, as the article talked a phase III trial that would help the patients along. From what I've seen, solid results will come down the pipeline in 2014, which would be great for those working in this field of research. I believe that, with so many details in existence, it seems like even more of them will be able to help those afflicted in the long run.
About the Author:
Contact Voices Against Brain Cancer if you're searching for more information about glioblastoma research.